BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Singh P, Singh A, Shah S, Vataliya J, Mittal A, Chitkara D. RNA Interference Nanotherapeutics for Treatment of Glioblastoma Multiforme. Mol Pharm 2020;17:4040-66. [PMID: 32902291 DOI: 10.1021/acs.molpharmaceut.0c00709] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
Number Citing Articles
1 Wang J, Chen G, Liu N, Han X, Zhao F, Zhang L, Chen P. Strategies for improving the safety and RNAi efficacy of noncovalent peptide/siRNA nanocomplexes. Adv Colloid Interface Sci 2022;302:102638. [PMID: 35299136 DOI: 10.1016/j.cis.2022.102638] [Reference Citation Analysis]
2 Karlsson J, Luly KM, Tzeng SY, Green JJ. Nanoparticle designs for delivery of nucleic acid therapeutics as brain cancer therapies. Adv Drug Deliv Rev 2021;179:113999. [PMID: 34715258 DOI: 10.1016/j.addr.2021.113999] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
3 Liu D, Cheng Y, Qiao S, Liu M, Ji Q, Zhang BL, Mei QB, Zhou S. Nano-Codelivery of Temozolomide and siPD-L1 to Reprogram the Drug-Resistant and Immunosuppressive Microenvironment in Orthotopic Glioblastoma. ACS Nano 2022. [PMID: 35549164 DOI: 10.1021/acsnano.1c09794] [Reference Citation Analysis]
4 Sharma S, Pukale S, Sahel DK, Singh P, Mittal A, Chitkara D. Folate targeted hybrid lipo-polymeric nanoplexes containing docetaxel and miRNA-34a for breast cancer treatment. Mater Sci Eng C Mater Biol Appl 2021;128:112305. [PMID: 34474856 DOI: 10.1016/j.msec.2021.112305] [Reference Citation Analysis]
5 DeSouza PA, Qu X, Chen H, Patel B, Maher CA, Kim AH. Long, Noncoding RNA Dysregulation in Glioblastoma. Cancers (Basel) 2021;13:1604. [PMID: 33807183 DOI: 10.3390/cancers13071604] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Wei C, Wang P, Huang Z, He D, Zhu W, Liu H, Chen Z, Wang W, Li Y, Shen J, Qin L. Construction of Surface-Modified Polydopamine Nanoparticles for Sequential Drug Release and Combined Chemo-Photothermal Cancer Therapy. Mol Pharm 2021;18:1327-43. [PMID: 33530691 DOI: 10.1021/acs.molpharmaceut.0c01164] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Li N, Sun Y, Fu Y, Sun K. RNA Drug Delivery Using Biogenic Nanovehicles for Cancer Therapy. Front Pharmacol 2021;12:734443. [PMID: 35002692 DOI: 10.3389/fphar.2021.734443] [Reference Citation Analysis]